Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best penny stocks under $1 to buy right now. On February 23, Gossamer Bio ...
Merck & Co. (MRK), known as MSD outside the United States and Canada, on Thursday reported positive second-season results from the Phase 3 SMART trial evaluating ENFLONSIA (clesrovimab) in infants and ...
InvestorsHub on MSN
Biofrontera reports positive phase 3 data for Ameluz in actinic keratosis
Biofrontera Inc. (NASDAQ:BFRI) said on Monday that its Phase 3 clinical study of Ameluz photodynamic therapy (PDT) successfully achieved its primary endpoint in the treatment of actinic keratoses ...
New York, NY (November 25, 2025) – An international team of investigators led by Emma Guttman-Yassky, MD, PhD, Waldman Professor and System Chair of the Kimberly and Eric J. Waldman Department of ...
Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...
Company Expects to Report Topline Data from OPUS-3 Trial and OPUS-2 Phase 3 Trial Evaluating Concomitant Administration of VAX-31 and a Seasonal Influenza Vaccine in First Half of 2027 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results